Real insight from the people actually doing the work: operators, engineers, and leaders across 17 B2B industries.
FDA’s interchangeable Wezlana nod for Stelara’s uses lands as interchangeability reviews speed up, a shift that changes formulary timing, pharmacy substitution
CDP spending is rising, but operations teams are rewriting specs around warehouse-native, zero-copy activation and consent controls.
Robert Half data shows UK employers planning headcount growth, while the World Economic Forum warns skill disruption is accelerating. Ops leaders should treat t
Vantage’s $25B “Frontier” plan in Texas lands as PwC sizes AI data center spend at $31.6T through 2050 and Frontier buyers add $915M more carbon removal demand.
One-minute audio briefs on the stories moving B2B across all 17 industries. Press play to catch up on what your market is acting on, then read the full story.
Get started
Book a 15-minute demo and we will map your experts to the content your market is searching for.
Or call us. No forms required. We pick up. 214-945-2512
The best thinking on B2B industries and the future of how markets communicate, delivered every Tuesday.
Join 3,000+ B2B marketing leaders. Unsubscribe any time.
Free workspace
These stories come from MarketScale. Create a free workspace and turn your own team's expertise into published media that buyers and AI engines actually cite. No credit card, no demo required.
NPS +73 · 1,000+ creators · 38+ countries
What you get, free
Real insight from the people actually doing the work: operators, engineers, and leaders across 17 B2B industries.
FDA interchangeable biosimilar approvals accelerating, reshaping formulary timing and pharmacy substitution workflows.
CDP buyers now mandate warehouse-native architecture, zero-copy activation, and granular consent controls over standalone platforms.
UK employers plan headcount growth, but skills gaps and WEF-warned disruption now pose schedule risk to expansion.
Vantage's $25B Texas AI campus shifts data center schedule risk to grid contracts and carbon removal capacity.
One-minute audio briefs on the stories moving B2B across all 17 industries. Press play to catch up on what your market is acting on, then read the full story.
Regulatory and operational approval cycles are accelerating across healthcare and enterprise software, collapsing traditional timelines for product launches and vendor integration.
Wezlana's faster interchangeable biosimilar pathway and OpenAI's Epic integration both signal how streamlined review and deployment are reshaping buyer and formulary planning cycles.
Read source ↗100%
Revenue leaders report AI use adoption
Salesloft’s 500-leader benchmark finds universal AI use in revenue teams, yet only 20.6% call it production-ready. The bottleneck is data quality and workflow f
Read source ↗Read source ↗“Operations teams are rewriting specs around warehouse-native, zero-copy activation and consent controls.”
— CDP market analysis
Get started
Book a 15-minute demo and we will map your experts to the content your market is searching for.
Or call us. No forms required. We pick up. 214-945-2512
The best thinking on B2B industries and the future of how markets communicate, delivered every Tuesday.
Join 3,000+ B2B marketing leaders. Unsubscribe any time.
